A team of researchers from Australia and China found that a drug prescribed to treat stroke victims could alleviate the progressive mental deterioration of Alzheimer's disease.
Edaravone, a commonly prescribed drug in Asia for those who have suffered a stroke, shows significant reversal of mental decline typically associated with Alzheimer's disease. Scientists hope the drug may help in improving memory as well as learning abilities.
Edaravone prevents the accumulation of toxins that steadily degenerates cells that eventually leads to loss of cognitive functions.
Researchers tested the drug on mice; the team showed that the drug effectively blocks the toxin function of the amyloid beta cells. The drug effectively fights the primary causes of Alzheimer's disease.
Researchers said that further research is needed to know whether the drug could help people with Alzheimer's disease. Edaravone cannot be prescribed unless the drug passes human trials in which patients are being specifically treated for Alzheimer's disease.